Patrick W. Smith

Filings by Patrick W. Smith span 2 companies, the busiest being Axon Enterprise, Inc. and Insight Molecular Diagnostics Inc. Between 17 May 2021 and 8 September 2026, the trades on record add up to 199 filings.

Both buying and selling appear: 5 purchases worth €2.3M, against 162 sales worth €192.2M. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 7 share grants and 22 option exercises. Since January 2026: no purchases and 73 sales on the market.

Half of the purchases are above €12k and half below. 3 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 10 September 2026 with an open-market sale (€592k) in Axon Enterprise, Inc. The last purchase on record was published on 11 February 2025, which is 614 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.